CommercialPrior AuthLow impact
Autologous Hematopoietic Stem-Cell Transplantation for Malignant Astrocytomas and Gliomas
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology, Neurosurgery +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi updated their policy on autologous hematopoietic stem-cell transplantation for malignant astrocytomas and gliomas, confirming these procedures remain investigational and not covered. The policy requires prior authorization through Case Management for any transplant procedures or evaluations.
Action Required
Immediately: Billing team must ensure prior authorization is obtained through BCBS Mississippi Case Management before billing any hematopoietic stem cell transplant procedures for brain tumor patients. Update billing system to flag these codes as investigational/non-covered for BCBS Mississippi members. Claims will be denied without prior authorization.